USANA Health Sciences, Inc. (N:USNA)

Business Focus: Special Foods & Welbeing Products

Sector:  Consumer Non-Cyclicals Industry:  Food Processing
 
See Regulatory Filings on SEC
Company Contact
Address: 3838 W Parkway Blvd
SALT LAKE CITY UT 84120-6336
Tel: N/A
Website: https://www.usana.com
IR: See website
<
Key People
Kevin G. Guest
Executive Chairman of the Board
Brent L. Neidig
Chief Commercial Officer
Jim H. Brown
President, Chief Executive Officer
G. Douglas Hekking
Chief Financial Officer
Walter Noot
Chief Operating Officer
Paul A. Jones
Chief People Officer
Daniel A. Macuga
Chief Communications and Marketing Officer
Robert A. Sinnott
Chief Scientific Officer
P. Joshua Foukas
Chief Legal Officer, General Counsel and Corporate Secretary
David Mulham
Chief Sales Officer
   
Business Overview
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company's product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.
Financial Overview
For the fiscal year ended 30 December 2023, USANA Health Sciences, Inc. revenues decreased 8% to $921M. Net income decreased 8% to $63.8M. Revenues reflect Greater China segment decrease of 5% to $475.1M, Americas and Europe segment decrease of 8% to $180.6M. Net income also reflects Interest expense increase of 36% to $262K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $3.60 to $3.31.
Employees: 1,800 as of Feb 23, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $521.37M as of Dec 30, 2023
Annual revenue (TTM): $921.01M as of Dec 30, 2023
EBITDA (TTM): $105.81M as of Dec 30, 2023
Net annual income (TTM): $63.79M as of Dec 30, 2023
Free cash flow (TTM): $56.15M as of Dec 30, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 19,240,514 as of Feb 23, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.